Yuyu Pharma, Inc.
000225.KS
Get informed when a big investor buys or sells
+ FollowMarket Cap$60.47B
Close$
Share Statistics
| Market cap | $60.47 Billion |
|---|---|
| Enterprise Value | $71.71 Billion |
| Dividend Yield | $125.00 (2.99%) |
| Earnings per Share | $492 |
| Beta | 0.36 |
| Outstanding Shares | 15,747,462 |
Return
| Return on Equity | 9.28% |
|---|---|
| Return on Assets | 6.01% |
| Return on Invested Capital | 2.47% |
Valuation & Multiples
| P/E Ratio | 5.14 |
|---|---|
| PEG | 0.3 |
| Price to Sales | 0.39 |
| Price to Book Ratio | 0.39 |
| Enterprise Value to Revenue | 0.5 |
| Enterprise Value to EBIT | 18.19 |
| Enterprise Value to Net Income | 5 |
| Total Debt to Enterprise | 0.45 |
| Debt to Equity | 0.24 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Yuyu Pharma, Inc.
248 employees
CEO: Wonsang Yu Yuyu Pharma, Inc. specializes in the development and commercialization of pharmaceutical products. Its extensive portfolio of prescription medications addresses a wide range of conditions, including osteoporosis, disorders related to bra...